eXoZymes Inc(EXOZ)

盘前9.83-0.29-2.87%08:15 EDT

10.12-0.53-4.98%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
eXoZymes Inc
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.invizyne.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
eXoZymes Inc.于2019年在内华达州成立。eXoZymes成立的目的是利用自然的构建块来制造感兴趣的分子，有效地简化自然。eXoZymes是一家生物技术开发公司，是一家拥有多数股权的子公司。eXoZymes的技术是一个差异化和独特的合成生物学平台，旨在实现对自然界中发现的大量分子和特性的可扩展探索。
- 04:30
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 04:30
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 03-31
  年度报告
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 02-21
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 02-11
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-11-18
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-11-18
  超过5%披露
  Form SC 13D - General Statement of Acquisition of Beneficial Ownership
  Form SC 13D - General Statement of Acquisition of Beneficial Ownership
- 2024-11-18
  超过5%披露
  Form SC 13D - General Statement of Acquisition of Beneficial Ownership
  Form SC 13D - General Statement of Acquisition of Beneficial Ownership
- 2024-11-18
  超过5%披露
  Form SC 13D - General Statement of Acquisition of Beneficial Ownership
  Form SC 13D - General Statement of Acquisition of Beneficial Ownership
- 2024-11-18
  超过5%披露
  Form SC 13D - General Statement of Acquisition of Beneficial Ownership
  Form SC 13D - General Statement of Acquisition of Beneficial Ownership
- 2024-11-12
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-11-06
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-11-06
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-10-31
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-10-25
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence